Bank of Montreal
BCTX

Bank of Montreal’s Briacell Therapeutics BCTX Stock Holding History

Bank of Montreal’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-234
Closed -$19.7K – 3494
2024
Q4 		$19.7K Sell
234
-2
-0.8% -$240 ﹤0.01% 3257
2024
Q3 		$27.4K Sell
236
-140
-37% -$15.7K ﹤0.01% 3530
2024
Q2 		$72.1K Sell
376
-519
-58% -$147K ﹤0.01% 3342
2024
Q1 		$521K Buy
895
+534
+148% +$294K ﹤0.01% 2411
2023
Q4 		$319K Buy
361
+110
+44% +$78.9K ﹤0.01% 2826
2023
Q3 		$265K Buy
251
+20
+9% +$19.6K ﹤0.01% 2899
2023
Q2 		$217K Buy
231
+63
+38% +$62.2K ﹤0.01% 3175
2023
Q1 		$187K Buy
168
+98
+140% +$102K ﹤0.01% 3048
2022
Q4 		$49.1K Hold
70
– – ﹤0.01% 3547
2022
Q3 		$61 Buy
+70
New +$70.2K ﹤0.01% 3576

Other funds holding BCTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

Bank of Montreal's BCTX Position: Q1 2025 in Review

Bank of Montreal sold out of Briacell Therapeutics (BCTX) in Q1 2025, closing a stake of 234 shares — an estimated $19.7K sold.

Bank of Montreal first reported a position in BCTX in Q3 2022 and held it in 10 quarters. The position peaked at $521K in Q1 2024. 13 funds tracked by Wall St. Rank hold BCTX as of Q1 2025.

  • Bank of Montreal reported no remaining Briacell Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 234 Briacell Therapeutics shares in Q1 2025, an estimated $19.7K.
  • Bank of Montreal first reported a position in Briacell Therapeutics in Q3 2022 and held it in 10 quarters.
  • Bank of Montreal's Briacell Therapeutics position peaked at $521K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.